Spire Healthcare Group (LON:SPI) Trading 14.1% Higher - Still a Buy?

Key Points

• Spire Healthcare Group's share price surged by 14.1%, hitting a high of GBX 256.50 during mid-day trading, significantly increasing from its previous close of GBX 216.50.
• Research analysts maintain an average rating of "Buy" for the stock, with a consensus price target of GBX 294.33, although JPMorgan lowered their price objective slightly to GBX 303.
• The company reported a net margin of 1.96% for the last quarter, with a projected earnings per share of 15.66 for the current year.

Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) rose 14.1% on Friday . The stock traded as high as GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33). Approximately 9,747,062 shares traded hands during trading, an increase of 563% from the average daily volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.92).

Analysts Set New Price Targets

Several research analysts have commented on the company. Berenberg Bank reaffirmed a "buy" rating and set a GBX 280 price target on shares of Spire Healthcare Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. dropped their target price on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a report on Tuesday, August 5th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average target price of GBX 294.33.

Spire Healthcare Group Stock Performance

The stock has a 50-day simple moving average of GBX 218.75 and a 200 day simple moving average of GBX 203.41. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74. The company has a market capitalization of £993.86 million, a PE ratio of 5,369.57, a P/E/G ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. Equities analysts anticipate that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.